Loading clinical trials...
Loading clinical trials...
The purpose of this study is to collect blood samples from women carrying a vanishing twin pregnancy to further develop Natera's non-invasive prenatal screening test to provide information about possi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Natera, Inc.
NCT07643896 · Pregnant Individuals, Aneuploidy, and more
NCT06783725 · Down Syndrome, Down Syndrome (Trisomy 21)
NCT07234695 · Down Syndrome, Down Syndrome (DS), and more
NCT07413224 · Down Syndrome (Trisomy 21)
NCT06938542 · Trisomy 13 Syndrome, Arthrogryposis Congenita Multiplex With Intestinal Atresia, and more
Center for Fetal Medicine & Women's Ultrasound
Los Angeles, California
Stanford
Palo Alto, California
University of Colorado
Aurora, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions